For Type 1 diabetics, further proof of improving your life using technology.
Medtronic gives hope to the type 1 diabetics as it sets the stage of them getting closer to the future of an artificial pancreas device as their clinical study proved that an insulin pump can automatically stop the flow of insulin once it detects that the blood sugar level had normalized.
These insulin pumps were developed by the medical technology company based in Minnesota and already available in over 50 countries outside US. Once the FDA approves the device, approximately 3 million Americans will benefit from it
http://www.hngn.com/articles/6075/20130623/medtronic-sets-stage-further-development-artificial-pancreas.htm